These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21136835)

  • 1. Proteomics in diabetic nephropathy.
    Kim HJ; Yoo HS; Kim CW
    Proteomics Clin Appl; 2008 Mar; 2(3):301-11. PubMed ID: 21136835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics and diabetic nephropathy.
    Merchant ML; Klein JB
    Curr Diab Rep; 2005 Dec; 5(6):464-9. PubMed ID: 16316599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
    Zhu C; Liang QL; Hu P; Wang YM; Luo GA
    Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics and diabetic nephropathy.
    Merchant ML; Klein JB
    Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of diabetic nephropathy in the proteomic era.
    Thongboonkerd V
    Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic biomarkers of diabetic nephropathy.
    Ito H; Fujita H; Takahashi T
    Expert Opin Med Diagn; 2008 Feb; 2(2):161-9. PubMed ID: 23485136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of diabetic nephropathy].
    Rychlík I
    Vnitr Lek; 2008 May; 54(5):488-93. PubMed ID: 18630634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy: a frontier for personalized medicine.
    Susztak K; Böttinger EP
    J Am Soc Nephrol; 2006 Feb; 17(2):361-7. PubMed ID: 16407421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical considerations concerning progressive diabetic renal diseases. Severe complications of early onset diabetes mellitus.
    Corniţescu G; Moţa M; Moţa E; Stănescu L
    Rom J Intern Med; 2003; 41(1):53-60. PubMed ID: 15529585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome analysis of serum from type 2 diabetics with nephropathy.
    Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
    J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress of proteomics in critical illness.
    Karvunidis T; Mares J; Thongboonkerd V; Matejovic M
    Shock; 2009 Jun; 31(6):545-52. PubMed ID: 19106823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker discovery in glomerular diseases using urinary proteomics.
    Thongboonkerd V
    Proteomics Clin Appl; 2008 Oct; 2(10-11):1413-21. PubMed ID: 21136790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic nephropathy -- a multifaceted target of new therapies.
    Choudhury D; Tuncel M; Levi M
    Discov Med; 2010 Nov; 10(54):406-15. PubMed ID: 21122472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
    Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications.
    Budhiraja S; Singh J
    Fundam Clin Pharmacol; 2008 Jun; 22(3):231-40. PubMed ID: 18485142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
    Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for diabetic nephropathy.
    Bruno S; Cattaneo D; Perico N; Remuzzi G
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):747-71. PubMed ID: 16262561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
    Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
    J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.